Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

PCDHGA12 Inhibitors

PCDHGA12 inhibitors constitute a distinct class of chemical compounds designed to selectively modulate the activity of the protocadherin gamma subfamily A member 12 (PCDHGA12) protein. Protocadherins, a subset of cell adhesion molecules, play pivotal roles in various physiological processes, particularly in the nervous system, where they contribute to neuronal development and the establishment of synaptic connections. PCDHGA12, belonging to the gamma subfamily, is specifically expressed in neural tissues, where it participates in intricate molecular interactions governing the formation and maintenance of neural circuits. The inhibitors developed for PCDHGA12 target the protein's unique structural features, engaging specific binding sites to interfere with its normal functioning at the molecular level.

The chemical structure of PCDHGA12 inhibitors is carefully crafted to ensure high specificity, preventing unintended interactions with closely related protocadherins. By disrupting the normal cellular activities associated with PCDHGA12, these inhibitors offer a tool for researchers to elucidate the precise molecular mechanisms underlying neural development and synaptic plasticity. The intricate interplay between PCDHGA12 and other cellular components underscores the significance of this chemical class in advancing our understanding of the fundamental processes governing neural circuit formation. As researchers delve deeper into the molecular intricacies of PCDHGA12 inhibition, this class of compounds may provide valuable insights into the broader landscape of cell adhesion and signaling pathways, with potential applications in elucidating neural development processes and related fields of scientific inquiry.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

5-Azacytidine may inhibit DNA methyltransferases, potentially leading to hypomethylation and altered gene expression of PCDHGA12.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

Similar to 5-Azacytidine, decitabine may lead to DNA demethylation and potentially suppress PCDHGA12 expression.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Vorinostat, an HDAC inhibitor, might change the chromatin structure around the PCDHGA12 gene, potentially decreasing its expression.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A can inhibit histone deacetylase, possibly leading to altered chromatin and lower PCDHGA12 expression.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$131.00
$515.00
2
(1)

RG108 could prevent DNA methylation, potentially reducing expression of genes like PCDHGA12.

Disulfiram

97-77-8sc-205654
sc-205654A
50 g
100 g
$53.00
$89.00
7
(1)

Disulfiram can modulate the epigenetic landscape, potentially leading to changes in gene expression, including PCDHGA12.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

Mithramycin A binds GC-rich sequences in DNA, potentially affecting the transcription of genes such as PCDHGA12.

Valproic Acid

99-66-1sc-213144
10 g
$87.00
9
(1)

Valproic acid is known to inhibit HDAC, which could potentially result in altered PCDHGA12 expression.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

Sodium butyrate, as an HDAC inhibitor, may induce histone hyperacetylation and affect PCDHGA12 expression.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Chloroquine can alter DNA replication and transcription, potentially affecting PCDHGA12 gene expression.